Gala review
Low dose, yearly term
$149 a month for tirzepatide — a lower-dose protocol, billed against a yearly subscription.
Our verdict
The price is genuinely low for tirzepatide, and the two reasons why are both worth understanding before signing. It is a reduced-dose protocol rather than the standard titration, and the figure is attached to a yearly term. Neither is disqualifying; both change what you are comparing when you put $149 next to another seller's number.
Disclosure: GLP Loss is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
At a glance
- Category
- compounded tirzepatide
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- Dose pricing
- Flat across doses
- States
- 50
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
- Pharmacy
- Not named
- Availability
- 50 states
- Updated
- September 2026
What it is
A GLP-1 telehealth service prescribing compounded tirzepatide on a lower-dose protocol, sold on an annual subscription with an accompanying app.
How it works
Prescription-gated telehealth with a yearly commitment. The protocol is built around doses below the standard escalation schedule, which the service presents as its approach rather than as a cost-saving measure.
Pricing transparency
$149 a month for tirzepatide, against a yearly subscription. A semaglutide figure also appears on the site but is quoted over a period longer than a month, so it does not belong in a monthly comparison.
Branded vs compounded
Compounded tirzepatide. Compounded drugs are not FDA-approved and are not reviewed by the FDA for safety, efficacy or quality before dispensing.
Pros and watch-outs
What we like
- $149 is low for tirzepatide
- All fifty states
- The dose approach is stated rather than buried
- An app is included in the subscription
Watch-outs
- A yearly term, not a rolling month
- A reduced-dose protocol is not what the trials tested
- The semaglutide figure on the site is not a monthly rate
- Compounding pharmacy is not named
Best for
Buyers who have decided on a low-dose approach and will commit to a year.
Who should look elsewhere
Anyone who wants the standard titration, or a month-to-month arrangement.
How Gala compares
A few alternatives worth a look, depending on what you’re optimizing for.
- Oak
Flat dose pricing without a subscription
See Oak → - Synergy Rx
Both molecules in both forms
See Synergy Rx → - Care Bare Rx
A single entry price, if you are starting on semaglutide
See Care Bare Rx →
More compounded tirzepatide sellers reviews: EdessaEffectyEverSlimFidelity Medical ClinicFMmedsFound
Editor · Reviewed and last verified September 2026
How we assessed this. This review reflects GLP Loss’s own read of Gala’s publicly-stated model — pricing transparency, clinical oversight, medication clarity, and access — against our editorial methodology. We publish no fabricated ratings or first-hand outcomes. A partnership never changes the assessment — see how we make money.
Frequently asked
- Why is Gala's tirzepatide cheaper than most?
- Two reasons, both stated on its own pages: the protocol uses doses below the standard escalation schedule, and the $149 is attached to a yearly subscription rather than a rolling month.
- Is a low-dose tirzepatide protocol as effective?
- There is no trial that answers this. SURMOUNT-1 reported −20.9% mean weight reduction at 15 mg weekly across 2,539 adults (PMID 35658024); a protocol pitched below the standard schedule is a different regimen with no readout of its own. Ask the prescriber what dose you would actually be on and what the evidence for it is.
- Is Gala a yearly commitment?
- The $149 figure is quoted against a yearly subscription. Confirm the cancellation terms before starting, because a year at $149 is $1,788 and that is the real unit being sold.
- Does Gala sell semaglutide too?
- A semaglutide figure appears on its site, but it is quoted over a term longer than a month, so it cannot be compared against another seller's monthly rate without converting it first.
- Is Gala legit?
- Gala is a compounded tirzepatide sellers service. Its stated availability: 50 states. What our record does not establish: whether it bills insurance and how its intake works. Ask for those in writing before you pay.
- Is Gala expensive compared with other compounded tirzepatide sellers providers?
- Gala publishes a starting figure of $149/mo. Across the 59 compounded tirzepatide sellers providers we review that publish a single monthly figure, those run $79 to $369 with a median of $150, which puts Gala below the median, toward the cheaper end. The other 1 compounded tirzepatide sellers providers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.